New discovery starts drug development for pancreatic cancer

Scientists, funded by your kindness, have taken the first step towards a new and urgently needed targeted treatment for pancreatic cancer. The UK team of researchers, led by Dr Sharon Rossiter, discovered several new compounds that inhibit S100P, a protein that is known to play a detrimental role in tumour progression and metastasis in pancreatic, as well as several other cancers.

We hope this will lead to new medicines that can slow the spread of pancreatic cancer and other cancers where this protein is involved, also helping other current treatments to be more effective.

Dr Sharon Rossiter University of Hertfordshire, United Kingdom

Pancreatic cancer remains one of the most lethal cancers.

And while survival rates for other cancers have increased in the last 40 years, less than 7% of people with pancreatic cancer currently survive for 5 years or longer in the UK. A lack of ways to diagnose this cancer early and the largely asymptomatic nature of the disease means that most people are diagnosed at an advanced stage when treatments such as chemotherapy are not as effective.

To identify potential new drugs for pancreatic cancer, the researchers first created a computer model of the S100P protein. They then screened a database of potential drug-like compounds that fit into the S100P protein in a way that would stop it from functioning properly. From this, they were able to identify several compounds that were able to target pancreatic cancer cells.

The study showed that it is possible to design small molecules to specifically target the S100P protein, leading the way to develop these into a potential drug treatment. This is still very early on in the drug development process which can take several years to reach clinical trials, but the next steps are exciting.

The researchers aim to design even better molecules that block S100P more strongly, whilst not affecting other similar proteins in the body, so these can be further developed towards a safe and effective treatment for patients.

Incredible discoveries like this would not happen without research – and research cannot happen without the support of people like you. If you’re feeling inspired, why not help us make the breakthroughs of the future by donating and starting new cancer cures today?

Donate now & become a Curestarter

Be part of a united effort to stop lives being cut short by cancer.

Related news

Worldwide Cancer Research team working at desk
News and press
New website launch
New Worldwide Cancer Research website launched
News and press
Exciting new immunotherapy breakthrough
Exciting new immunotherapy breakthrough
News and press
Four incredible examples of bowel cancer research
Four incredible examples of bowel cancer research
Share this page